1-20 of 28
Xudong Wei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor, in Combination with Azacitidine in Treatment of Patients with Myelodysplastic Syndrome (MDS)

Huafeng Wang, Xudong Wei, Yang Liang, Jianyu Weng, Wenjuan He, Chunkang Chang, Suning Chen, Hongbing Ma, Zi Chen, Lichuang Men, Lihui Liu, Xiaohong Tian, Zhang Zhang, Danhua Cong, Dajun Yang, Yifan Zhai, Jie Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 3202.
https://doi.org/10.1182/blood-2024-205371
Published: 2024
Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Yuqian Sun, Lixin Wu, Yicheng Zhang, Ya-Jing Xu, Xiaobing Huang, Baodong Ye, Hailong Yuan, Jianying Zhou, Sujun Gao, Fang Zhou, Yue Liu, Xianmin Song, Yu Cai, Xiaoliang Liu, Yi Luo, Luxin Yang, Jianmin Yang, Libing Wang, Yuhua Li, Rui Huang, Shunqing Wang, Ming Zhou, Yujun Dong, Qian Wang, Yimei Feng, Xin Du, Wei Ling, Han Zhu, Zunmin Zhu, Xiangli Chen, Shiyun Wang, Fankai Meng, Kehong Bi, Ning Huang, Ming Jiang, Ting Niu, Jie Ji, Dingming Wan, Bian Zhilei, Yi Chen, Li Liu, Xueqian Yan, Xi Yang, Hai Yi, Xudong Wei, Xin Li, Qian Cheng, Chenglu Yuan, Wen Wang, Yuhong Zhou, Yu-Hong Chen, Fengrong WANG, YuanYuan Zhang, Zhi-Dong Wang, Xiao-Dong Mo, Wei Han, Jing-Zhi Wang, Yu Wang, Huan Chen, Xiangyu Zhao, Ying-jun Chang, Kaiyan Liu, Jia Feng, LanPing Xu, Hongyu Zhang, Xi Zhang, Xiaojun Huang, Xiaohui Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 2187.
https://doi.org/10.1182/blood-2024-206919
Published: 2024
Journal Articles

A First-in-Human Phase 1/2 Study of the Menin-KMT2A(MLL1) Inhibitor BN104 in Adult Patients with Relapsed or Refractory Acute Leukemia

Depei Wu, Ying Wang, Suning Chen, Yuhua Li, Rui Huang, Jinhai Ren, Xiaoling Guo, Yan Li, Mingyuan Sun, Xudong Wei, Ruihua Mi, Xiaoyu Zhu, Anyou Wang, He Huang, Yi Luo, Dengju Li, Jin Yin, Xiaojing Yan, Ran Gao, Fei Li, Yu Wang, Bryan Huang, Ye Hua
Journal: Blood
Blood (2024) 144 (Supplement 1): 2879.
https://doi.org/10.1182/blood-2024-198959
Published: 2024
Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: An Updated Report on the Pivotal Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-Cell ALL) in China

Wang Ying, Lulu Lv, Yongping Song, Xudong Wei, Hongsheng Zhou, Qifa Liu, Kailin Xu, Dongmei Yan, Cheng Zhang, Shuangyou Liu, Jie Jin, Heng Mei, Ting Niu, Aibin Liang, Runxia Gu, Chunmei Zheng, Yi Feng, Wenqiu Huang, Shuai Xin, Wei Jin, Lin Shi, Yongzeng Wang, Jianxiang Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4196.
https://doi.org/10.1182/blood-2024-199983
Published: 2024
Journal Articles

Preliminary Results of Patients with Myelofibrosis (MF) from a Phase I Trial of Jab-8263, a Potent BET Inhibitor

Junyuan Qi, Bo Jiang, Wei Yang, Xudong Wei, Hongmei Jing, Yongping Song, Andrea Wang-Gillam, Yuli Ding, Chao Bi, Ting Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4567.
https://doi.org/10.1182/blood-2024-209977
Published: 2024
Journal Articles

A Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter Study

Jianying Zhou, Song Wang, Ting Niu, Ming Jiang, Shunqing Wang, Wen Wang, Xi Zhang, Yujun Dong, Dingming Wan, Xin Du, Xudong Wei, Han Zhu, Yuhua Li, Kehong Bi, Xianmin Song, Yi Chen, Li Liu, Yi Luo, Yuhong Zhou, Xin Li, Yajing Xu, Yicheng Zhang, Xiaoliang Liu, Hai Yi, Xiaobing Huang, Zunmin Zhu, Jianmin Yang, Fang Zhou, Xiaohui Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4951.
https://doi.org/10.1182/blood-2023-184407
Published: 2023
Journal Articles

Efficacy and Safety of Clifutinib, a Novel, Highly Selective, Oral FLT3 Inhibitor, in Patients with FLT3-Mutated Relapsed or Refractory Acute Myeloid Leukemia：Updated Results from a Phase I Study

Jie Jin, Huafeng Wang, Wen-Juan Yu, Zheng Ge, Xudong Wei, Yuhua Li, Zhongxing Jiang, Yiqing Li, Xin Du, Linhua Yang, Lie Lin, Jishi Wang, Yazhou Yao, Xiaoping Hu, Jianping Lan, Xiuzhi Deng, Tong Chen, Xianqi Feng, Dengju Li, Ming Hou, Rong Fu, Siyong Huang, Jingbo Wang, Xin Du, Hui Yang, Haiping Yang, Yingzhi Jiang, Zhijie Wang, Deng Li, Bing Liu, Ning Kang, Yulei Zhuang, Yingjun Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4281.
https://doi.org/10.1182/blood-2023-188961
Published: 2023
Journal Articles

Alrizomadlin (APG-115) Alone or Combined with Azacitidine (AZA) in Patients (pts) with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Relapsed or Progressive Higher-Risk Myelodysplastic Syndrome (HR-MDS): Phase 1b Trial Results

Junyuan Qi, Xudong Wei, Qiubai Li, Chukang Chang, Fuling Zhou, Jianying Huang, Yu Zhang, Chongyuan Xu, Xiaowen Tang, Qian Jiang, Junmin Li, Qun Qin, Qun He, Sujun Gao, Liping Liu, Zi Chen, Min Yu, Jing Wang, Lichuang Men, Hengbang Wang, Mohammad Ahmad, Dajun Yang, Yifan Zhai, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5954.
https://doi.org/10.1182/blood-2023-184959
Published: 2023
Journal Articles

Heritable SETBP1 Mutations Associated with Myelodysplastic Syndrome and Acute Myeloid Leukemia

Jingyi Yang, Shanlan Mo, Xudong Wei, Xiaodong Lv, Ya Zhang, Yuewen Fu, Baijun Fang, Yanli Zhang, Jian Zhou, Hu Zhou, Quande Lin, Delong Liu, Yongping Song, Qianfei Wang, Keshu Zhou
Journal: Blood
Blood (2023) 142 (Supplement 1): 5684.
https://doi.org/10.1182/blood-2023-182788
Published: 2023
Journal Articles

The Diversity of FLT3-ITD and the Prognostic Impact in Adult Acute Myeloid Leukemia

Jingyi Yang, Shanlan Mo, Xudong Wei, Xiaodong Lv, Baijun Fang, Yanli Zhang, Jian Zhou, Hu Zhou, Yuewen Fu, Quande Lin, Delong Liu, Yongping Song, Qianfei Wang, Keshu Zhou
Journal: Blood
Blood (2023) 142 (Supplement 1): 5756.
https://doi.org/10.1182/blood-2023-178989
Published: 2023
Journal Articles

Safety and Efficacy of Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor (BCL-2i), in Relapsed or Refractory (R/R) or Treatment-Naïve (TN) Patients (Pts) with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), or Other Myeloid Neoplasms

Huafeng Wang, Xudong Wei, Qian Jiang, Wenjun He, Qiubai Li, Yang Liang, Jianyu Weng, Suning Chen, Hongbing Ma, Chukang Chang, Yajing Xu, Qun He, Zi Chen, Lihui Liu, Lichuang Men, Danhua Cong, Zhang Zhang, Dajun Yang, Yifan Zhai, Jie Jin, IV
Journal: Blood
Blood (2023) 142 (Supplement 1): 2925.
https://doi.org/10.1182/blood-2023-188489
Published: 2023
Journal Articles

A Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Junyuan Qi, Lin Song, Xudong Wei, Zhimin Zhai, Anyou Wang, Daozi Jiang, Yang Liang, Fei Li, Zhongxing Jiang, Xuejun Zhang, Qunyi Guo, Hongmei Jing, Yajing Xu, Xiangmin Tong, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2908.
https://doi.org/10.1182/blood-2023-183088
Published: 2023
Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China

Ying Wang, Xudong Wei, Dongmei Yan, Cheng Zhang, Hongsheng Zhou, Chunrong Tong, Heng Mei, Jie Jin, Ting Niu, Aibin Liang, Jienan Ren, Yiping Deng, Wei Jin, Yi Feng, Lin Shi, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Jianxiang Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 1598–1600.
https://doi.org/10.1182/blood-2022-165002
Published: 2022
Journal Articles

Phase I Study of TQB3455, a Selective Inhibitor of IDH2 with Favorable Safety and More Potent Efficacy to IDH2-R172K Mutation, for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Hao Jiang, Xudong Wei, Chunkang Chang, Hongbing Ma, Xuejun Zhang, Xiao-Jun Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9082–9083.
https://doi.org/10.1182/blood-2022-164984
Published: 2022
Journal Articles

Molecular Biomarker Analyses for Exploring the Therapeutic Mechanism of Lemzoparlimab and Azacitidine (AZA) in Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS)

Zhijian Xiao, Chunkang Chang, Qiubai Li, Xiaojing Yan, Tiejun Qin, Hongyan Tong, Yu Zhang, Min Dai, Yanjie He, Jianyu Weng, Jian Li, Sujun Gao, Rong Fu, Xudong Wei, Aili He, Jinhai Ren, Tong Wu, Xin Du, Yanni Zhang, Ke Xu, Zhengyi Wang, Michelle Yang, Andrew Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 8821–8822.
https://doi.org/10.1182/blood-2022-163880
Published: 2022
Journal Articles

Delays in Time to Deterioration of Health-Related Quality of Life Were Observed in Patients with Acute Myeloid Leukemia Receiving Venetoclax in Combination with Azacitidine or in Combination with Low-Dose Cytarabine

Keith W. Pratz, MD, Panayiotis Panayiotidis, MD, Christian Recher, MD PhD, Xudong Wei, PhD, Brian A Jonas, MD PhD, Pau Montesinos, MD PhD, Vladimir Ivanov, Andre C. Schuh, Courtney D. Dinardo, MDMSc, Jan Novak, Vlatko Pejsa, MD PhD, Don A. Stevens, MD, Su-Peng Yeh, MD, Inho Kim, MD PhD, Mehmet Turgut, MD, Nicola Fracchiolla, Kazuhito Yamamoto, MD PhD, Yishai Ofran, MD, Andrew H Wei, MBBS, PhD, Cat Bui, Katy Benjamin, Rajesh Kamalakar, MS, Jalaja Potluri, MD, Wellington Mendes, Jacob Devine, Walter Fiedler, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–35.
https://doi.org/10.1182/blood-2020-133912
Published: 2020
Journal Articles

Combined Thalidomide and Recombinant Human Interferon-α-1b and Interleukin-2 for Acute Myeloid Leukemia of Various Disease Status: A Multi-Center Prospective Study

Ruihua Mi, Lin Chen, MD, Xudong Wei, PhD, Xiaojiao WANG, Yongping Song, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3865.
https://doi.org/10.1182/blood-2019-128431
Published: 2019
Journal Articles

All-Trans Retinoic Acid Enhances the Anti-Leukemia Effect of Venetoclax on Acute Myeloid Leukemia Cells

Dongbei Li, Sha Liu, Lin Chen, MD, Ruihua Fan, Cheng Cheng, Xudong Wei, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5055.
https://doi.org/10.1182/blood-2019-128551
Published: 2019
Journal Articles

Arsenic Trioxide Synergistically Enhances the Antileukemia Activity of Bcl-2 Inhibitor ABT-199 in Acute Myeloid Leukemia

Sha Liu, Lin Chen, MD, Xiaojiao Wang, Ruihua Mi, Qingsong Yin, Ruihua Fan, Xudong Wei, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2555.
https://doi.org/10.1182/blood-2019-129543
Published: 2019
Journal Articles

Autologous Hematopoietic Stem Cell Infusion for Myelosuppression after Bcma-CART Therapy in Relapsed Myeloma Patients

Quande Lin, PhD, Lu Han, MS, Jian Zhou, MD PhD, Lina Liu, Master, Yuzhang Liu, master, Fengkuan Yu, Master, YangLi Zhang, Master, Wenli Zuo, Doctor, Keshu Zhou, MD, Baijun Fang, MD, Quanli Gao, Doctor, Xudong Wei, PhD, Delong Liu, MD PhD, Yongping Song, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1851.
https://doi.org/10.1182/blood-2019-128410
Published: 2019